Evaluating chronic venous disease with a new venous severity scoring system  by Ricci, Michael A et al.
From the American Venous Forum
Evaluating chronic venous disease with a new
venous severity scoring system
Michael A. Ricci, MD,a Joseph Emmerich, MD, PhD,d Peter W. Callas, PhD,b Frits R. Rosendaal, MD,e,f
Andrew C. Stanley, MD,a Shelly Naud, PhD,b Carla Vossen, MSc,e and Edwin G. Bovill, MD,c
Burlington, Vt; Paris, France; and Leiden, The Netherlands
Background: The Venous Clinical Severity Score (VCSS) has been proposed by the American Venous Forum as an
objective means to clinically assess venous disease more completely than with the clinical CEAP classification. However,
validation of the VCSS against an objective test is lacking. The purpose of this study was to test the VCSS against
abnormalities found on venous ultrasound (US) scans.
Methods: As part of a screening project in a large kindred population with protein C deficiency, VCSS and venous US
scanning were performed in 210 patients (420 limbs). A single examiner scored the VCSS (0-3) clinically for pain,
varicose veins, edema, skin pigmentation, inflammation, induration, ulcer duration and size, and compressive therapy.
Another experienced examiner, blinded to the subject’s medical history, performed a US examination of the deep and
superficial venous system, with a hand-carried US system. The relationship between US and VCSS scores was analyzed by
calculating an odds ratio (OR) and its 95% confidence interval (CI).
Results: Of the 420 limbs screened, VCSS was 0 in 283 limbs, and VCSS was 1 or greater in the following categories: pain,
63 limbs; varicose veins, 70 limbs; edema, 51 limbs; skin pigmentation, 17 limbs; inflammation, 2 limbs; induration, 8
limbs; and compressive therapy, 9 limbs. The highest total score in any limb was 8. A clear association was seen with the
VCSS and abnormalities found on US scans. When the score was dichotomized (0 normal, 1 any abnormality), it was
a strong predictor of US scan abnormalities; limbs with VCSS greater than 0 had a 26-fold greater chance of US scan
abnormalities than did limbs with VCSS  0 (OR, 26.5; 95% CI, 11-64). With ultrasonography as the standard,
sensitivity of VCSS compared with US scans was 89.3%, and specificity was 76.1%. Negative predictive value of VCSS 
0 was 97.9%, and positive predictive value for any positive score was 36.5%
Conclusions: The results of this study are based on a large kindred population with a higher risk for venous disease than
found in the general population. Though the VCSS was devised to quantify the severity of chronic venous disease, this
study found it a useful screening tool. The VCSS showed good association with abnormalities on US scans, and when
VCSS  0 there is a high likelihood that the patient does not have venous disease. This simple test may prove valuable in
clinical practice. (J Vasc Surg 2003;38:909-15.)
In an attempt to standardize outcome assessment of
venous interventions, an ad hoc committee of the American
Venous Forum (AVF) developed a clinical scoring system,
the Venous Clinical Severity Score (VCSS),1 meant to
expand and supplement the existing CEAP classification
system.2 In addition, the Venous Segmental Disease Score
(VSDS) has been proposed to complement the VCSS,
allow scoring with duplex ultrasound (US) scanning, and
combine the anatomic and pathophysiologic components
of CEAP.1 Meissner et al3 determined intraobserver varia-
tion with VCSS to be minimal, whereas interobserver vari-
ation in three of 10 categories (pain, inflammation, pig-
mentation) was significant. Interobserver agreement
regarding presence or absence of disease (as defined by a
score of 3 or 8) was good (  0.59 and 0.65).3
However, the clinical aspects of VCSS have not been vali-
dated against an objective test such as venous US scanning.
This study was designed to test the association of venous
abnormalities detected with US scanning with the VCSS
and the “C” (Clinical) component of the CEAP classifica-
tion.
METHODS
As part of a population study of a large pedigree of
patients who share protein C deficiency as a result of a rare
C insertion mutation,4-6 210 persons from Vermont and
Quebec, Ont, Canada, were studied prospectively between
July and November 2002. The propositus for these kindred
was a teenager with deep venous thrombosis. The popula-
tion study included a large homogeneous group of persons
with and without protein C deficiency and with or without
a history of symptomatic deep vein thrombosis or pulmo-
nary embolism. The University of Vermont Committee on
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Human Research approved the experimental protocol and
consent form, and all subjects provided informed consent.
Patients were assessed according to clinical signs of the
CEAP classification,2 which combine clinical data (discom-
fort, swelling, ulceration) and objective data observed at
ultrasonography (Table I). In addition, clinical data for
each patient was scored by a single investigator (J.E.) using
the VCSS1 (Table II), which has been validated as reliable.3
Each abnormality observed on US scans was scored by an-
other investigator according to VSDS criteria (Table III), and
each limb was scored according to the Venous Disability Score
(VDS) described by Rutherford et al.1 Calf perforating veins
or other veins in the calf were not scored, which is allowed in
this system.1 Both clinical examination and venous ultra-
sonography were performed by clinicians blinded to medical
history of venous thrombosis and protein C status.
Table I. Characteristics of CEAP classification
Clinical classification
Class 0 No visible or palpable signs of venous disease
Class 1 Telangiectasias, reticular veins, malleolar flare
Class 2 Varicose veins
Class 3 Edema without skin changes
Class 4 Skin changes ascribed to venous disease (eg, pigmentation, venous
eczema, lipodermatosclerosis)
Class 5 Skin changes with healed ulceration
Class 6 Skin changes with active ulceration
Etiologic classification
Congenital (EC) Cause present since birth
Primary (EP) Undetermined cause
Secondary (ES) Associated known cause (eg, postthrombotic, posttraumatic, other)
Anatomic classification (may include one, two,
or three systems in any combination)
Superficial (AS) Superficial veins
Deep (AD) Deep veins
Perforating (AP) Perforating veins
Pathophysiologic classification
Reflux (PR) Venous reflux
Obstruction (PO) Venous outflow obstruction
Both (PR,O)
Table II. Venous Clinical Severity Score
Attribute Absent  0 Mild  1 Moderate  2 Severe  3
Pain None Occasional, not restricting
activity or requiring
analgesic agents
Daily moderate activity
limitation; occasional
analgesic agents
Daily, severe limiting
activities or requiring
regular use of analgesic
agents
Varicose veins (4 mm
diameter)
None Few, scattered; branch veins Multiple; greater saphenous
veins, confined to calf or
thigh
Extensive; thigh and calf, or
greater and lesser
saphenous distribution
Venous edema None Evening ankle edema only Afternoon edema, above
ankle
Morning edema above ankle
and requiring activity
change, elevation
Skin pigmentation None or focal,
low intensity
(tan)
Diffuse, but limited in area
and old (brown)
Diffuse over most of gaiter
distribution (lower 1/3)
or recent pigmentation
(purple)
Wider distribution (above
lower 1/3) plus recent
pigmentation
Inflammation None Mild cellulitis, limited to
marginal area around ulcer
Moderate cellulitis, involves
most of gaiter area (lower
1/3)
Severe cellulitis (lower 1/3
and above) or significant
venous eczema
Induration None Focal, circummalleolar ( 5
cm)
Medial or lateral, less than
lower third of leg
Entire lower third of leg or
more
Number of active ulcers 0 1 2 2
Active ulcer duration None 3 months 3 months, 1 year Not healed 1 year
Active ulcer diameter (cm) None 2 2-6 6
Compression therapy Not used or
patient not
compliant
Intermittent use of stockings Wears elastic stockings most
days
Full compliance; stockings 
elevation
For complete description, see reference 1.
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Venous US scanning was performed in each patient
with a hand-carried ultrasonography system (SonoSite
180PLUS; SonoSite, Bothell, Wash) by a single experi-
enced clinician (J.E.). A solid-state 10-5 MHz 38-mm
broadband linear array transducer was used (maximum
depth, 7 cm), except in obese patients, in whom a 5-2 MHz
60-mm broadband curved array was used (maximum
depth, 22 cm). Patients were examined in the supine posi-
tion, with the head of the bed elevated 15 to 30 degrees.
Transverse compression was performed approximately ev-
ery 2 cm through the entire length of the vein being
examined by applying downward pressure to the transducer
until complete cooptation of the anterior and posterior
walls of the vein was achieved. Compression began in the
common femoral vein just below the inguinal ligament, and
proceeded distally through the saphenofemoral junction,
the confluence of the profunda femoral vein and the super-
ficial femoral vein, and continued down the limb along the
anteromedial thigh through the length of the superficial
femoral vein. Next the popliteal vein was imaged from a
posterior approach, and compression was performed with
the patient sitting. Once the deep veins were completely
examined, the greater and lesser saphenous veins were
imaged along their length.
Venous Doppler scanning was performed coincident
with the patient standing erect with weight on the con-
tralateral leg. Pulsed-wave Doppler scanning of the veins
was performed in a longitudinal plane, with the 10.5 MHz
transducer, with the cursor parallel to the vein wall, an
angle of 60 to 45 degrees, and the sample gate centered in
the vein. Spectral display was obtained in all veins previ-
ously imaged in the B-mode examination. The entire prox-
imal deep venous system, and the greater and lesser saphe-
nous veins were examined for the presence of reflux, with
the Valsalva maneuver and distal augmentation. If the
patient was unable to stand, Doppler scanning was per-
formed with the patient positioned the same as for the
B-mode examination.
Interpretation criteria were defined in advance of pa-
tient enrollment. In the standing position, reflux was de-
fined as abnormal valve closure time that produced greater
than 0.5- second reversal of venous flow, as described.7,8 In
addition, the normal veins demonstrated the following
characteristics: slightly larger diameter than that of the
adjacent artery when the limb was dependent; vein enlarge-
ment with the Valsalva maneuver or proximal compression;
and completely compressible, spontaneous, phasic (with
respiration) flow that was augmented with distal compres-
sion and with release of Valsalva or proximal compression at
Doppler US scanning or color flow scanning. Thrombus
was indicated by inability to compress the vein, echogenic
material within the vein lumen, dilated vein, absent or
decreased spontaneous flow, loss of phasicity, or absent or
decreased augmentation. Obstruction, as defined for the
VSDS,1 was defined as greater than 50% luminal narrowing,
on the basis of uncompressed residual luminal diameter
compared with vein diameter.
Sensitivity and specificity of VCSS in detecting venous
disease were estimated with the venous ultrasonography
findings as the standard. Positive and negative predictive
values in this population of patients were similarly esti-
mated. The association between VCSS greater than 0 and
US scan abnormalities was quantified by computing the
odds ratio (OR) and its 95% confidence interval (CI). The
Fisher exact test was used for statistical analysis.
RESULTS
Venous ultrasonography was performed, and CEAP
classification and VCSS were determined in 210 patients
(420 limbs). Mean age of patients was 43.8 years (SD, 14.9
years; median, 43.0 years; range, 15-78 years). Fifty-eight
percent of patients were female. Thirteen percent had a
known history of venous thrombosis, and 46% had protein
C deficiency. History of thrombosis was present in 19% of
patients with protein C deficiency and 8% of patients with-
out protein C deficiency (P  .04). In 22 of 210 patients
(10%), edema score was greater than 0 in both legs.
In those patients, US scans demonstrated no anatomic
abnormality in 364 limbs (87%), compared with at least one
abnormality in the remaining 56 limbs (13%). Clinical
CEAP classification in these patients is shown in Table IV.
Fifty-two of 364 limbs (14.3%) without anatomic US scan
abnormalities had a clinical classification greater than 1,
compared with 37 of 56 limbs (66.1%) with US scan
abnormalities (P .0001). Significantly more patients with
anatomic abnormalities had a score of 3 or greater (P 
.0001). Thirty-one patients (8.5%) had a score of 3 or
greater. When clinical CEAP classification was dichoto-
mized (0 or1 or greater, or3 and3), it was unable to
reliably predict US scan abnormalities (Table V), although
Table III. Venous Segmental Disease Score
Score Vein
Reflux*
1⁄2 Lesser saphenous vein
1 Greater saphenous vein
1⁄2 Perforator vessels, thigh
1 Perforator vessels, calf
2 Calf veins, multiple (posterior tibial vein alone, 1)
2 Popliteal vein
1 Superficial femoral vein
1 Profunda femoris vein
1 Common femoral vein and above
Obstruction (excision, ligation, traumatic obstruction,
thrombosis)*
1 Greater saphenous vein (only if thromboses from
groin to below knee level)
1 Calf veins, multiple
2 Popliteal vein
1 Superficial femoral vein
1 Profunda femoris vein
2 Common femoral vein
1 Iliac vein
1 Inferior vena cava
For complete description, see reference 1.
*Maximum score  10; not all 11 segments can be involved in reflux or
obstruction.
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negative predictive value in either instance remained high
(94.3%, 89.8%).
VCSS is shown in Table VI. In this group, only four
patients had VCSS greater than 4 without US scan evidence
of abnormality. Significantly more patients in the group
with anatomic abnormality had VCSS greater than 4 (29%;
P  .0001). When VCSS was dichotomized (Table VII),
patients with VCSS greater than 0 were found to have a
26-fold greater odds of US scan abnormalities than those
with VCSS  0 (OR, 26.5; 95% CI, 11-64). Negative
predictive value was high (97.9%). Therefore, if VCSS 
zero, the likelihood of finding an abnormality on venous
US scans was extremely low (3%). Conversely, in two
thirds of patients with VCSS 3 or greater, an abnormality
was observed on venous US scans. For CEAP and VCSS,
sensitivity is better for VCSS, specificity is better for CEAP,
and predictive values are similar.
Anatomic or functional abnormalities observed in-
cluded complete obstruction, partial obstruction (eg, evi-
dence of thrombus, thickened vein wall), and reflux. Several
patients demonstrated anatomic evidence of obstruction
(50% diameter, not scored) and reflux. Specific abnormal-
ities and VSDS are listed in Table VIII. Of 51 patients with
a score greater than zero, average VSDS score was 1.37.
VSDS reflux score (only one patient had an obstruction
score) was significantly related to VCSS (Table IX; P 
.0001).
VDS for each limb is listed in Table X. Only 74 patients
had a score greater than 1, and in 47 of these patients no
anatomic abnormality was observed on US scans. For pur-
poses of analysis, the score was dichotomized as 0 or greater
than 1. Surprisingly, 11% of 420 limbs had no US scan
abnormality, but had VDS of 1 or greater. When VDS is
correlated with VCSS, a high degree of correlation is noted
(r  0.59; P  .0001; Table XI). If both VCSS and VDS
are dichotomized (0 or 1), the association is highly
significant (P  .0001).
For the 44 legs with objective evidence of venous
disease (obstruction score0 [n 1] or reflux score0 [n
 43], correlation was determined between VCSS, CEAP,
and VDS. These three measures were moderately corre-
lated in the 44 limbs: VCSS and CEAP, correlation coeffi-
cient  0.33, P  .03; VCSS and VDS, correlation coeffi-
cient 0.40, P .01; and for CEAP and VDS, correlation
coefficient  0.38, P  .01. P values indicate that these
correlations are significantly different from zero.
DISCUSSION
In 1994 a consensus committee of the AVF developed
the CEAP classification of chronic venous insufficiency2 as
a means to improve simple classification of reporting stan-
dards published by vascular societies.9 Although the CEAP
classification could be used to gauge clinical severity of
disease at a single point in time, it was not useful for
assessing change.1 Many of its elements are fairly static, for
example, presence of subcutaneous fibrosis; others do not
Table IV. Clinical CEAP classification
CEAP class
Limbs with no
anatomic
abnormality
n (%)
Limbs with
anatomic
abnormality
n (%) P
0 312 (85.7) 19 (33.9) .0001
1 15 (4.1) 3 (5.4)
2 6 (1.7) 16 (28.6)
3 31 (8.5) 18 (32.1)
Table V. Dichotomized CEAP clinical classification
Limbs with no
anatomic
abnormality
Limbs with
anatomic
abnormality Total
A. 0 or 1*
0 312 19 331
1 52 37 89
364 56 420
B. 3 or 3†
3 333 38 371
3 31 18 49
364 56 420
*P  .0001; sensitivity, 66.1%; specificity, 85.7%; positive predictive value,
41.6%; negative predictive value, 94.3%.
†P  .0001; sensitivity, 32.1%; specificity, 91.5%; positive predictive value,
36.7%; negative predictive value, 89.8%.
Table VI. Venous Clinical Severity Score
Score
Limbs with no
anatomic
abnormality
n (%)
Limbs with
anatomic
abnormality
n (%) P
0 277 (76) 6 (11) .0001
1 54 (15) 14 (25)
2 20 (5) 10 (18)
3 9 (2) 10 (18)
4-8 4 (1) 16 (29)
Table VII. Dichotomized Venous Clinical Severity Score
Limbs with no
anatomic
abnormality
Limbs with
anatomic
abnormality Total
A. 0 or 1*
0 277 6 283
1 87 50 137
364 56 420
B. 3 or 3†
3 351 30 381
3 13 26 39
364 56
*P  .0001; sensitivity, 89.3%; specificity, 76.1%; positive predictive value,
36.5%; negative predictive value, 97.9%.
†P  .0001; sensitivity, 46.4%; specificity, 96.4%; positive predictive value,
66.7%; negative predictive value, 92.1%.
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necessarily change significantly even with treatment, for
example, presence of telangiectasias).1 In addition, clinical
classification was not reliably reproduced by different ob-
servers,10 although recent efforts have attempted to im-
prove on this.11 Consequently, a subsequent ad hoc com-
mittee of the AVF developed the VCSS to supplement and
enhance the clinical portion of the CEAP classification.1
The VCSS system includes 10 clinical descriptors (pain,
varicose veins, venous edema, skin pigmentation, inflam-
mation, induration, number of active ulcers, duration of
active ulceration, size of ulcer, and compressive therapy
use), scored from 0 to 3 (total possible score, 30) that may
be used to assess changes in response to therapy.1
Meissner et al3 attempted to validate the VCSS by
assessing its reproducibility with the same and different
examiners. Three observers classified 64 patients (128
limbs) with chronic venous insufficiency (including asymp-
tomatic limbs) on the same day, and a single observer
scored limbs 7 to 28 days apart for determination of in-
traobserver variation. Intraobserver variation was low, with
scores differing only by 0.8, resulting in a reliability coeffi-
cient of 0.6. Scores for different observers varied by a mean
of 0.8 (observers 1 and 3; P .03) or 0.4 (observer 3; P
11), but were not statistically significant overall (P  .02),
with scores for pain, skin pigmentation, and inflammation
differing slightly. Agreement was good, with   0.59 for
absence of disease and   0.65 for detecting presence of
severe disease.3
In addition, Meissner et al3 reported that a VCS score
of 3 or less was associated with sensitivity of 76% and
specificity of 90% for absence of disease, and a score of 8 or
Table VIII. Ultrasound abnormalities and Venous Segmental Disease Score
Ultrasound findings Frequency
Obstruction
score*
Reflux
score
Complete obstruction, GSV 1 1 0
Complete obstruction, LSV 1 0 0
Partial obstruction, CFV; reflux, GSV 1 0 1
Partial obstruction, CFV; reflux/partial obstruction, POP 1 0 2
Partial obstruction, CFV; reflux, POP 4 0 2
Partial obstruction/reflux, GSV 2 0 1
Partial obstruction, LSV 5 0 0
Partial obstruction, POP 2 0 0
Partial obstruction/reflux, POP 7 0 2
Partial obstruction/reflux, LSV 2 0 0
Reflux, GSV 15 0 1
Reflux, LSV 2 0 0
Reflux/partial obstruction, POP; CFV 1 0 3
Reflux/partial obstruction, POP; partial obstruction, LSV 1 0 2
Partial obstruction/reflux, SFV 1 0 1
Reflux, POP 8 0 2
Reflux, POP, LSV 1 0 2
Reflux, POP, GSV 1 0 3
GSV, Greater saphenous vein; LSV, lesser saphenous vein; CFV, common femoral vein; SFV, superficial femoral vein; POP, popliteal vein.
*No score assigned for partial obstruction (see text).
Table IX. Venous Segmental Disease Score: reflux score
versus VCSS
VCSS
Reflux score
0 1 2-3
0 282 0 1
1 57 0 11
2 22 6 2
3 10 5 4
4 6 8 6
VCSS, Venous Clinical Severity Score.
P  .0001
Table X. Dichotomized Venous Disability Score: 0 or
1
Score
Limbs with no
anatomic
abnormality
n (%)
Limbs with
anatomic
abnormality
n (%) P
0 317 (87) 29 (52) .0001
1 47 (13) 27 (48)
Sensitivity, 48.2%; specificity, 87.1%; positive predictive value, 36.5%; neg-
ative predictive value, 91.6%.
Table XI. VCSS correlation with Venous Disability Score
VCSS
Venous Disability Score
0 1
0 276 7
1 47 21
2 11 19
3 8 11
4 4 16
VCSS, Venous Clinical Severity Score.
P  .0001
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more demonstrated similar sensitivity of 70% and specificity
of 96% for presence of disease. Although no subject in this
study had VCSS greater than 8, as indicated in Table VII, B,
a score of 3 or less was sufficiently discriminating for
absence of disease to produce a negative predictive value of
92.1%; a score of 3 or greater, however, had a positive
predictive value of only 66.7%.
Meant primarily as a mechanism to score treatment
outcome for venous disease, VCSS has not been validated
against an objective, anatomic assessment tool, such as
venous ultrasonography. Indeed, until recently, determina-
tion of chronic venous insufficiency has been difficult,
indirect, or inaccurate.7 A variety of tests, including photo-
plethysmography, air and strain gauge plethysmography,
static and dynamic venous pressure, and continuous wave
Doppler scanning, can detect presence of reflux, but they
cannot identify the specific venous segments involved.7,8,12
Duplex US scanning has proved accurate for detection of
presence of deep and superficial vein thrombosis. Signs of
previous deep venous thrombotic episodes include abnor-
mally thickened vein walls, recanalized flow channels, and
abnormally small venous segments. With duplex US scan-
ning, deep and superficial venous reflux can be accurately
identified with direct anatomic assessment.8,12 Patient po-
sitioning is important when assessing for venous reflux with
duplex US scanning. The standing position increases dila-
tion of the venous system, which improves the quality of
the US scan, and because reflux is mainly the result of
gravity, standing also enhances venous reflux detection.7,8
Various stimuli, such as manual or pneumatic augmenta-
tion of the proximal and distal limb segments or the Val-
salva maneuver, can elicit reflux.7 In the standing position,
reflux can be defined as abnormal valve closure time that
produces greater than 0.5-second reversal of venous
flow.7,8
A unique aspect of this study is that all patients were
examined with both the clinical VCSS and the anatomic
VSDS, something not previously reported in the same
patient population. Even though the prevalence of severe
disease was low, anatomic score correlated well with clinical
score. This adds support for use and reliability of the clinical
scoring system, and validates the anatomic system as a
useful tool. Because all the veins in the calf were not
interrogated in this population, this study underestimated
the number of abnormalities, despite the fact that the VCSS
enables evaluation of fewer than all 18 venous segments in
the score.1 If asymptomatic calf vein thrombosis were more
frequent in this population, abnormalities could have been
missed, and would not have been scored. In addition,
minor abnormalities on US scans, such as vein wall thick-
ening or minor luminal obstruction, suggested the pres-
ence of disease, but not severe enough to tally a score with
the VSDS. It may be that this score is insensitive to more
minor abnormalities on US scans, particularly with regard
to obstruction. Table VIII demonstrates that a variety of
abnormal disease patterns do not result in increased VSDS
score.
Perhaps the most difficult aspect of the original CEAP
classification2 or its modification1 is the estimate of disabil-
ity. Twenty-nine patients with abnormal US scans had VDS
of zero, whereas 47 patients with no US scan abnormality
had a score of 1 or greater (meaning they were unable to
carry out daily activities without wearing compression
stockings). Similarly, among those with CEAP clinical class
3 or greater, 31 of 49 limbs (63%) demonstrated no evi-
dence of venous disease on US scans. One must conclude
that clinical assessment tools are still extremely insensitive,
or that US diagnosis is inaccurate or insensitive in chronic
venous disease. Other tests for venous disease, such as air
plethysmography or venography, may have demonstrated
abnormalities in patients with clinically suspected venous
disease. In addition, it cannot be excluded that some pa-
tients with normal US scans complained of leg pain or
edema, subjective symptoms that can also be due to venous
insufficiency.
In this study, venous US scanning enabled detection of
abnormalities in this patient population at high risk
thought to be asymptomatic, as seen in our preliminary
analysis.6 Presence of superficial venous reflux, the most
common abnormality, was similar to that found in a study
of healthy patients by van Bemmelen et al.13 However,
equally important was the finding that a negative VCSS was
unlikely to be associated with any significant abnormality
seen on venous duplex US scans. The study has drawbacks,
in that few patients had severe venous disease, and its use in
patients with most severe disease may still be in question.
While the CEAP classification and VCSS had equally high
negative predictive values, the CEAP classification is not
intended to respond to changes over time, and thus is not
useful as a clinical tool to assess treatment. Correlation
between VCSS and VSDS was high, a finding not previ-
ously reported. However, it is possible that predictive val-
ues would be different in a population with a different
prevalence of chronic venous disease. It is likely that nega-
tive predictive value would decrease in a population with a
higher prevalence of superficial venous insufficiency,
whereas positive predictive value might be improved. On
the other hand, this study population is at much higher risk
for deep vein thrombosis compared with the general pop-
ulation, which argues for use the CEAP clinical classifica-
tion and VCSS, not only for superficial venous insuffi-
ciency, but also for venous insufficiency related to sequelae
of deep vein thrombosis. Our results show that both VCSS
and VSDS are tools that the vascular specialist can use to
objectively assess outcome of treatment of venous disease.
Use of these scoring systems is being implemented in the
vascular clinics at the authors’ institutions. Although not
the originally intended use of this scoring system, it may be
that VCSS can be used as a screening tool in the clinical
setting, though this will require prospective validation.
Such a screening function for VCSS would be of great
use in investigation and management of venous thrombo-
embolic disease in the setting of genetically determined
thrombophilic families, similar to the subjects of this study.
Among members of the kindred with protein C deficiency,
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50% were affected by age 50 years, which emphasized the
devastating effect of the disease in this population. Investi-
gative efforts would be enhanced by improved definition of
clinical disease, especially propensity for chronic venous
insufficiency and identification of individuals with subclin-
ical disease. The latter group improves the classification of
affected individuals for assessment of genetic risk factors.
Clinical management would be improved by more effective
prediction of chronic sequelae and possibly recurrent dis-
ease.
We thank Maryanne Waters, RN, RVT, and Tom Day,
RVT, for technical assistance in developing the ultrasonog-
raphy protocols.
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